To pet or not to pet? That is the question. Staging in anal cancer

Annals of Oncology

Volumn 23, Issue 8, 2012, Pages 2078-2082

  Bhuva, N J ^a   Glynne Jones, R ^a   Sonoda, L ^a   Wong, W L ^a   Harrison, M K ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Anal; Cancer; Lymph nodes; PET CT; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL RECTAL EXAMINATION; DISTANT METASTASIS; HUMAN; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UNITED KINGDOM;

ANUS NEOPLASMS; COMBINED MODALITY THERAPY; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864960093     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr599     Document Type: Article

References (14)

1. Cancer Information/Anal Cancer 2010; www.macmillan.org.uk (August 2011, date last accessed).
2. SEER Stat Fact Sheets: Anal Cancer 2010; http://seer.cancer.gov (August 2011, date last accessed).
3. Cancer Research UK Statistics/Anal Cancer 2009; www.cancerhelp.org.uk (July 2011, date last accessed).
4. UKCCCR Anal Cancer Working Party Epidermoid anal cancer: results from the UKCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C. Lancet 1996; 348: 1049-1054.
5. Bartlink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomised trial of the European Organisation for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040-2049.
6. Glynne-Jones R, Northover J, Oliveira J. ESMO Guidelines Working Group; Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl 4): 57-60.
7. Shepherd NA, Scoffield JH, Love SB et al. Prognostic factors in anal squamous cell carcinoma: a multivariant analysis of clinical, pathological and flow cytometric perimeters in 235 cases. Histopathology 1990; 16: 545-555.
8. James R, Meadows H, Wan S ACT II: the second UK phase III anal cancer trial (editorial). Clin Oncol 2005; 17: 364-366.
9. Krengli M, Milia ME, Turri L et al. FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Radiat Oncol 2010; 5: 10.
10. de Winton E, Heriot AG, Ng M et al. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 2009; 100: 693-700.
11. Trautmann T, Zuger J Positron emission tomography for pre-treatment staging and post-treatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005; 7: 309-313.
12. Cohn D, Dehdashti F, Gibb R et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynaecol Oncol 2002; 85: 179-184.
13. Reinhardt M, Ehritt-Braun C, Vogelgesang D et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001; 218: 776-782.
14. Pepek JM, Willett CG, Wu QJ et al. Intensity-modulted radiation therapy for anal malignancies: a preliminary toxicity and disease outcome analysis. Int J Radiat Oncol Biol Phys 2010; 78 5: 1413-1419.